To date, there is scarce research guiding treatment for pediatric patients with head and neck cancers. To change this, Aldo V. Londino, MD, is leading efforts to discover trends involving these patients. So far, his team has found that pediatric differentiated thyroid cancer might be associated with worse pathologic and short-term outcomes than those among adults.